Miroslav Peřina - Concepedia

Author

Miroslav Peřina

Palacký University Olomouc ORCID

Also Known As

Miroslav Perina, Miroslav Peřina, Peřina, Miroslav

Publications

202

Citations

H-Index

Concepts

All Affiliations

Palacký University Olomouc Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences, Institute of Experimental Botany Czech Academy of Sciences, Institute of Molecular Genetics Czech Academy of Sciences

About

Miroslav Peřina is an author at Palacký University Olomouc specializing in medicine, health sciences, and cell death.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	44
2	Health Sciences	1	1	31
3	Natural Sciences	1	1	13
4	Biochemistry	1	1	13
5	Cell Biology	1	1	31

Miroslav Peřina

Publications

149

Citations

H-Index

Page 1

	Year	Citations
3,5,7-Substituted Pyrazolo[4,3-<i>d</i>]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders Radek Jorda, Libor Havlı́ček, Miroslav Peřina, Journal of Medicinal Chemistry	2022	33
Modulation of FLT3-ITD and CDK9 in acute myeloid leukaemia cells by novel proteolysis targeting chimera (PROTAC) Eva Řezníčková, Soňa Krajčovičová, Miroslav Peřina, European Journal of Medicinal Chemistry Mixed-phenotype Acute LeukemiaImmunologyCell DeathTumor BiologyMyeloid Neoplasia	2022	31
3,5,7-Substituted Pyrazolo[4,3-<i>d</i>]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models Radek Jorda, Libor Havlı́ček, Antonín Šturc, Journal of Medicinal Chemistry	2019	27
Synthesis of dihydrotestosterone derivatives modified in the A-ring with (hetero)arylidene, pyrazolo[1,5-a]pyrimidine and triazolo[1,5-a]pyrimidine moieties and their targeting of the androgen receptor in prostate cancer Márton A. Kiss, Miroslav Peřina, Václav Bazgier, The Journal of Steroid Biochemistry and Molecular Biology	2021	17
3<i>H</i>-Pyrazolo[4,3-<i>f</i>]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In Vivo Neetu Dayal, Eva Řezníčková, Delmis E. Hernandez, Journal of Medicinal Chemistry	2021	17
Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure Josef Jansa, Radek Jorda, Jana Škerlová, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryNatural SciencesMedicine-One Inhibitors	2021	13
Characterization of new highly selective pyrazolo[4,3-d]pyrimidine inhibitor of CDK7 Markéta Kovalová, Libor Havlı́ček, Stefan Djukic, Biomedicine & Pharmacotherapy	2023	11

Page 1